Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
While its not yet approved in Ireland, Retatrutide is currently in late-stage clinical trials, with availability expected from 2026 onwards
Research peptides intended for in vitro use from specialized suppliers belong to a completely separate domain from the pharmaceutical distribution network and are in no way a substitute for medications like Mounjaro, Wegovy, or Phase 3 molecules such as retatrutide
What Is the JRNYS GLP-1 Program
Pregnant women on insulin or SGLT2 inhibitors were more likely to experience diabetic complications
Key Distinctions How is Retatrutide different from other GLP-1 receptor agonists
Other GLP-1 agonists appear to have similar effects on fertility
US$ 21.94
US$ 24.21
US$ 23.30
US$ 21.98
US$ 23.41
US$ 22.76
